Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Cirrhosis

  Free Subscription


1 BMC Gastroenterol
1 Intern Med
1 J Gastroenterol Hepatol
1 J Hepatol
2 Lancet Gastroenterol Hepatol
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Gastroenterol

  1. ZHENG J, Zhang Y, Li P, Zhang S, et al
    The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study.
    BMC Gastroenterol. 2019;19:32.
    PubMed     Text format     Abstract available

    Intern Med

  2. YANG J, Lun Y, Shuai X, Liu T, et al
    Late-onset Hemochromatosis: Co-inheritance of beta-thalassemia and Hereditary Hemochromatosis in a Chinese Family: A Case Report and Epidemiological Analysis of Diverse Populations.
    Intern Med. 2018;57:3433-3438.
    PubMed     Text format     Abstract available

    J Gastroenterol Hepatol

  3. HANAI T, Shiraki M, Watanabe S, Imai K, et al
    Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: a propensity score-matching analysis.
    J Gastroenterol Hepatol. 2019 Feb 18. doi: 10.1111/jgh.14635.
    PubMed     Text format     Abstract available

    J Hepatol

  4. SINGH SP, Panigrahi S, Mishra D, Khatua CR, et al
    Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia.
    J Hepatol. 2019 Feb 16. pii: S0168-8278(19)30012.
    PubMed     Text format    

    Lancet Gastroenterol Hepatol

    Ensuring timely treatment of patients with primary biliary cholangitis.
    Lancet Gastroenterol Hepatol. 2018 Jul 12. pii: S2468-1253(18)30177.
    PubMed     Text format    

  6. POSE E, Gines P
    Transient elastography for alcoholic liver disease: a step forward.
    Lancet Gastroenterol Hepatol. 2018 Jul 5. pii: S2468-1253(18)30212.
    PubMed     Text format    

    PLoS One

  7. HARRISON SA, Dennis A, Fiore MM, Kelly MD, et al
    Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.
    PLoS One. 2018;13:e0203054.
    PubMed     Text format     Abstract available

  8. FRANSEN PETTERSSON N, Deronic A, Nilsson J, Hannibal TD, et al
    The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis.
    PLoS One. 2018;13:e0203228.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.